Skip to main content
MyPeptideMatch

O-304 (ATX-304)

Investigational

AMPK Activator (small molecule)

Blood Sugar ControlFat LossExercise Mimetic
Last reviewed October 2026MyPeptideMatch Team

O-304, also written O304 and now developed as ATX-304, is an experimental pill that switches on AMPK, an enzyme your cells use to sense when they're low on energy. Exercise turns on the same enzyme, which is why O-304 gets called an exercise mimetic. It was discovered at Umeå University in Sweden and is being tested for type 2 diabetes and obesity.

It's not a peptide. O-304 is a small molecule, even though many research peptide sites sell it. Three small human studies have been reported (a phase 1 safety study, a 28-day phase 2a trial and a phase 1b study), and all were short.

Key Takeaways
  • O-304 is an oral small molecule, not a peptide. ATX-304 is the same compound.
  • It activates all forms of AMPK. Lab studies in muscle cells found it also uncouples mitochondria, so cells burn more fuel.
  • In obese and diabetic mice, it improved blood sugar, insulin resistance and heart function.
  • In a 28-day trial in 65 people with type 2 diabetes, it lowered fasting blood sugar in a subgroup and lowered blood pressure.
  • In a 2026 study of 23 adults with obesity and prediabetes (about 15 on the drug), it raised resting energy use and cut liver and belly fat compared with their starting values.
  • It's not FDA approved. WADA bans AMPK activators as a class.
What it isSmall-molecule AMPK activator (C16H11Cl2N3O2S)
Molecular weightAbout 380 g/mol
Other namesO304, ATX-304
DeveloperBetagenon, now part of Amplifier Therapeutics
RouteOral
Doses in trials1,000 mg a day (28 days); 400 mg a day (8 to 16 weeks)
FDA statusInvestigational; not approved
In sportAMPK activators are prohibited (WADA S4)

What Is O-304?

O-304 was discovered by Helena Edlund, Thomas Edlund and the late Olof Karlsson, working at Umeå University and the Swedish company Betagenon.[1][2] Betagenon is now owned by Amplifier Therapeutics, part of Cambrian Bio, which develops the compound as ATX-304. Betagenon remains the sponsor of its trials.[2]

It's an oral small molecule. Its structure isn't built from amino acids, so calling it a peptide is a mislabel.

ATX-304 vs OS-01

Some sellers list "OS-01" as another name for O-304.[10] That name already belongs to an unrelated product: OneSkin's OS-01, a 10-amino-acid skin care peptide that reduced markers of aging skin cells in lab-grown skin.[3][11] ATX-304 is a pill that activates AMPK. If you search for OS-01, you'll find both.

How O-304 Works

AMPK is an enzyme that turns on when a cell runs low on energy, such as during exercise or fasting. Once active, it pushes cells to take up glucose and burn fat.

O-304 keeps AMPK switched on by stopping the chemical tag that activates it from being removed. It works on every form of the enzyme, which is why it's called a pan-AMPK activator.[1] Later lab work in muscle cells found it also acts as a mitochondrial uncoupler: it makes mitochondria burn fuel less efficiently, which raises the cell's demand for glucose.[4]

What People Use O-304 For

  • Blood sugar control. This is what it was developed for, as a type 2 diabetes treatment taken alongside metformin.
  • Fat loss. Its developer now plans to test it as a weight loss drug that works differently from GLP-1 drugs.[5]
  • Endurance and healthy aging. Biohackers use it as an exercise mimetic. The evidence for this is in aged mice.

The Research Behind O-304

Human studies

TELLUS, phase 2a (2018)[1]65 adults with type 2 diabetes on metformin1,000 mg a day, 28 daysLower fasting blood sugar in a subgroup; lower blood pressure; well tolerated
Phase 1b (2026)[5]23 adults with obesity and prediabetes400 mg a day, 8 weeks (optional extension to 16)Higher adiponectin, less liver and visceral fat, resting energy use up to 33% higher than baseline; safe and well tolerated

The 2018 diabetes trial was small and short. The authors call it an exploratory study. The blood sugar result comes from a post hoc analysis of the 49 patients whose starting blood sugar fell between 126 and 240 mg/dL, and the groups weren't well balanced at the start. In that group, fasting blood sugar fell by 0.60 mmol/L on O-304 versus 0.10 mmol/L on placebo. Blood pressure fell by 5.8/3.8 mmHg on O-304 and rose slightly on placebo.[1] The authors note the drop in blood sugar was modest compared with existing diabetes drugs.

The 2026 study reported changes from baseline. It was presented as a conference poster, not a full paper. Its results compare people with their own starting values rather than with the placebo group.[5]

Animal studies

Steneberg, 2018[1]Obese and diabetic miceMore glucose taken up by muscle, less insulin resistance, better heart pumping
Ericsson, 2021[6]Aged miceReversed age-related insulin resistance; better heart function and running endurance
Zhu, 2022[7]Naturally aging miceLess kidney scarring and fewer aging cells in the kidney
Norlin, 2023[4]Diabetic miceProtected insulin-making beta cells and reversed diabetic heart muscle damage

O-304 is an investigational drug. It isn't FDA approved, and because it's under study as a drug, it can't legally be sold as a dietary supplement. It hasn't been nominated for, and isn't on, FDA's 503A bulk substance lists for compounding.[8] Sellers market it as a research chemical.

In sports, the WADA Prohibited List bans activators of AMPK as a class under section S4.4.1 (metabolic modulators), at all times.[9] O-304 isn't named, but it's an AMPK activator, so tested athletes should treat it as banned.

O-304 Dosage

No approved dose

O-304 is still in early trials, so there's no approved dose. The amounts below come from those trials and from sellers. Talk to a licensed clinician before you take it, especially if you use diabetes medicine.

O-304 dosage chart

TELLUS diabetes trial[1]1,000 mg a day28 days
Phase 1b prediabetes study[5]400 mg once a day8 weeks, optional extension to 16
Online users50 to 400 mg a day, often split morning and middayVaries

Capsules sold online commonly contain 100 or 150 mg.[10][12] Their contents aren't verified, so they may not match the trial drug. O-304 stays in the body a long time: in the diabetes trial, blood levels took about 14 days to level off.[1]

O-304 Side Effects

In the two trials with published results, O-304 was reported as well tolerated.[1][5] In the 2018 trial it caused no ECG abnormalities and no change in heart muscle mass.[1]

What isn't known:

  • Long-term safety. The longest human exposure reported is 16 weeks.
  • Low blood sugar with other drugs. O-304 lowers blood sugar, so combining it with insulin, sulfonylureas or GLP-1 drugs could add to their effect. This hasn't been studied.
  • Product quality. Online capsules aren't made to drug standards, and the frequent mislabeling as a peptide or as OS-01 is a warning sign.

Who should avoid it: anyone pregnant or breastfeeding, anyone under 18, anyone on diabetes medicine without a doctor's supervision and athletes who are drug tested.

For more, see our posts on O-304 results and O-304 cost.

Frequently Asked Questions

What is O-304? An experimental pill that activates AMPK, the enzyme exercise switches on. It's being developed for diabetes and obesity.

Is O-304 a peptide? No. It's a small molecule with no amino acids.

Is ATX-304 the same as O-304? Yes. ATX-304 is the name its current developer, Amplifier Therapeutics, uses.

Is ATX-304 the same as OS-01? Not really. Some sellers use the name, but OS-01 is also an unrelated skin care peptide from OneSkin.

Does O-304 work? Early human studies show modest effects on blood sugar, blood pressure and liver fat. There are no large trials yet.

Does O-304 cause weight loss? In obese mice, yes. In people, it hasn't been shown.

What is the O-304 dose? Trials used 1,000 mg a day for 28 days and 400 mg a day for up to 16 weeks.

What are the side effects of O-304? It was well tolerated in short trials. Long-term effects are unknown.

Is O-304 legal? It's an investigational drug, not FDA approved and not a legal supplement.

Is O-304 banned by WADA? WADA bans AMPK activators as a class, so athletes should treat it as banned.

References

  1. Steneberg P, Lindahl E, Dahl U, et al. PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients. JCI Insight. 2018;3(12):e99114. PMID: 29925691
  2. Amplifier Therapeutics. Amplifier Therapeutics doses first patients in Phase 1B clinical trial. October 17, 2023. amplifier-tx.com
  3. Zonari A, Brace LE, Al-Katib K, et al. Senotherapeutic peptide treatment reduces biological age and senescence burden in human skin models. NPJ Aging. 2023;9(1):10. PMID: 37217561
  4. Norlin S, Axelsson J, Ericsson M, Edlund H. O304 ameliorates hyperglycemia in mice by dually promoting muscle glucose effectiveness and preserving β-cell function. Commun Biol. 2023;6(1):877. PMID: 37626210
  5. Thieroff-Ekerdt RI, Jacobs D, Hall J, et al. Phase 1b study of AMPK/mitochondrial activator ATX-304 in prediabetic obese participants. Diabetes. 2026;75(Suppl 1):1782-P. diabetesjournals.org
  6. Ericsson M, Steneberg P, Nyrén R, Edlund H. AMPK activator O304 improves metabolic and cardiac function, and exercise capacity in aged mice. Commun Biol. 2021;4(1):1306. PMID: 34795407
  7. Zhu M, Shen W, Li J, et al. AMPK activator O304 protects against kidney aging through promoting energy metabolism and autophagy. Front Pharmacol. 2022;13:836496. PMID: 35308246
  8. U.S. Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A. fda.gov
  9. World Anti-Doping Agency. The 2026 Prohibited List, section S4.4.1. wada-ama.org
  10. Umbrella Labs. O-304 (ATX-304) capsules, product listing. umbrellalabs.is
  11. OneSkin. OS-01 FACE moisturizer ingredient list (Decapeptide-52, the OS-01 peptide). oneskin.co
  12. Peptide Regenesis. AMPK O-304 (ATX-304, OS-01) 150 mg, product listing. peptideregenesis.com

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.

Where to Buy O-304 (ATX-304) for Research

Research Use Only — not intended for human consumption

1
Elite Research USA
$150.00
View Product

Research peptides are sold for laboratory use only and are not intended for human consumption.

Find Clinics Offering O-304 (ATX-304)

No clinics in our directory yet. Browse all clinics.

Find a Peptide Clinic Near You

Continue Reading

Articles about O-304 (ATX-304) and related topics

MyPeptideMatch.com does not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.